Stay updated on Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page.

Latest updates to the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page
- Check3 days agoChange DetectedA new Revision: v3.5.4 entry was added and the previous Revision: v3.5.3 entry was removed, updating the page's revision history to reflect the latest version.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check26 days agoChange DetectedAdded related topics: Rheumatoid arthritis and MedlinePlus Genetics, expanding the page's links to disease resources. This update enhances access to genetics and disease-specific information related to the study.SummaryDifference0.0%

- Check27 days agoChange DetectedUpdates to the study’s location details include added entries for specific administrative regions and cities (e.g., regional designations for Araucanía/Temuco, Moravian-Silesian/A Hlučín, Olomouc Region/Olomouc, Ādaži, and Bucharest), along with a revision version change. These changes reflect formatting/label adjustments rather than any alteration to the trial information or outcomes.SummaryDifference0.2%

- Check48 days agoChange DetectedAdded related topics: Rheumatoid arthritis and MedlinePlus Genetics to the page.SummaryDifference0.0%

- Check63 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check70 days agoChange DetectedRemoved related topics in the page's sidebar: 'Rheumatoid arthritis' and 'MedlinePlus Genetics'. This is a metadata/navigation change that does not modify the study details or results.SummaryDifference0.0%

Stay in the know with updates to Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page.